Rocket Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $590.8M
Liabilities Breakdown FY2020
Total Liabilities: $87.3M
Asset Breakdown
Total Assets: $590.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $297.1M | 50.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $19.2M | 3.3% |
| Goodwill | $30.8M | 5.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $243.7M | 41.2% |
Liabilities Breakdown
Total Liabilities: $87.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $87.3M | 100.0% |